Trial Profile
Trial of lesinurad in patients with gout and renal impairment.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Aug 2011
Price :
$35
*
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Pharmacodynamics
- 19 Jun 2010 Currently, four patients have completed dosing, according to an Ardea Biosciences media release.
- 19 Jun 2010 Status changed from planning to recruiting, based on an Ardea Biosciences media release.
- 22 Apr 2009 New trial record.